BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 63.34%
This Quarter Est. Return
1 Year Est. Return
+63.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.7B
AUM Growth
+$6.43B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
124
New
Increased
Reduced
Closed

Top Buys

1
+$134M
2
+$93M
3
+$83.3M
4
ADCT icon
ADC Therapeutics
ADCT
+$79M
5
ADAP
Adaptimmune Therapeutics
ADAP
+$29.9M

Top Sells

1
+$474M
2
+$101M
3
+$51.6M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$40.7M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$22.8M

Sector Composition

1 Healthcare 97.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$8.03B 35.43%
47,269,424
-2,790,816
2
$3.33B 14.67%
31,999,081
+20,296
3
$2.22B 9.79%
11,777,285
4
$2.03B 8.96%
41,904,586
5
$983M 4.34%
8,760,794
6
$936M 4.13%
7,589,294
7
$626M 2.76%
11,574,538
8
$501M 2.21%
3,390,270
9
$359M 1.58%
11,850,962
+2,750,347
10
$306M 1.35%
3,164,234
+1,390,000
11
$239M 1.05%
1,724,834
12
$230M 1.01%
1,019,557
13
$230M 1.01%
3,144,223
+223
14
$170M 0.75%
1,499,212
15
$161M 0.71%
1,409,784
16
$161M 0.71%
1,846,139
17
$111M 0.49%
906,986
-333,257
18
$94.5M 0.42%
1,580,873
-374,540
19
$93M 0.41%
+2,000,000
20
$90.5M 0.4%
13,713,195
21
$88.5M 0.39%
6,018,104
22
$83.3M 0.37%
3,025,384
23
$83.1M 0.37%
1,009,757
+120,000
24
$79M 0.35%
+1,687,500
25
$75.2M 0.33%
3,532,760
1
2 3 4 5